INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $17,000 | -65.3% | 15,000 | -42.1% | 0.00% | 0.0% |
| Q2 2018 | $49,000 | -18.3% | 25,900 | -9.4% | 0.00% | 0.0% |
| Q1 2018 | $60,000 | -1.6% | 28,600 | -38.4% | 0.00% | 0.0% |
| Q3 2017 | $61,000 | -78.0% | 46,400 | -77.4% | 0.00% | -85.7% |
| Q4 2016 | $277,000 | +242.0% | 205,700 | +294.8% | 0.01% | +133.3% |
| Q3 2016 | $81,000 | -48.7% | 52,100 | +73.1% | 0.00% | -62.5% |
| Q1 2016 | $158,000 | +85.9% | 30,100 | +198.0% | 0.01% | +33.3% |
| Q3 2015 | $85,000 | -28.6% | 10,100 | -7.3% | 0.01% | -66.7% |
| Q2 2015 | $119,000 | -31.2% | 10,900 | -15.5% | 0.02% | -45.5% |
| Q3 2014 | $173,000 | – | 12,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |